Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.61 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.61 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | AMY2A | P04746 | 3/20 | 0.54 |
| ▸ | TYR | P14679 | 2/20 | 0.50 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | GJA1 | P17302 | 1/20 | 0.49 |
| ▸ | GJB2 | P29033 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | IGF2R | P11717 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | MGAM | O43451 | 2/20 | 0.47 |
| ▸ | SI | P14410 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cellobiose SCHEMBL21511124 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL24202679 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL23708014 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL21206262 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL23752618 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL24662526 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Maltotriose SCHEMBL23467170 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Maltotriose SCHEMBL24202675 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL25382543 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A | |
| Cellobiose SCHEMBL21114355 | 1.00 | LGALS8 (0.61) | LGALS8LGALS3LGALS4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117957009-A | Methods and compositions for preventing and treating severe and severe specific infectious pneumonia (COVID-19) and chronic severe and specific infectious pneumonia (LONG COVID) | 段美南 | 2024-04-30 | — | — | CN | claimed |
| CN-102895132-B | Composition for detoxifying and purifying skin | JIANG JING | 2014-04-09 | — | — | CN | claimed |
| CN-102895132-A | Composition for detoxifying and purifying skin | JIANG JING | 2013-01-30 | — | — | CN | claimed |
| CN-101904436-B | Fish and shrimp polyculture compound feed and preparation method thereof | ZHANJIANG HENGXING SPECIAL FEED CO LTD | 2012-07-18 | — | — | CN | claimed |
| CN-101904436-A | Fish and shrimp polyculture compound feed and preparation method thereof | ZHANJIANG HENGXING SPECIAL FEED CO LTD | 2010-12-08 | — | — | CN | claimed |
| EP-4694908-A1 | GASTROINTESTINAL RETENTIVE FORMULATIONS OF ECHINOCANDINS | The Cleveland Clinic Foundation (US) | 2026-02-18 | — | — | EP | disclosed |
| WO-2025235840-A1 | ECHINOCANDIN-LIKE AND BORON-CONTAINING ECHINOCANDIN COMPOUNDS AND THEIR USE AS AGROCHEMICAL FUNGICIDES | 5METIS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4522126-A1 | TOPICAL FORMULATION COMPRISING OMEGA-3 FATTY ACIDS, MELATONIN AND VITAMIN D | Ambo Innovation LLC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20250009787-A1 | Nitric Oxide Containing Foam Formulation for Topical Medical Use | NOXY HEALTH PRODUCTS, INC. | 2025-01-09 | — | — | US | disclosed |
| US-20240382517-A1 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | NOXY HEALTH PRODUCTS, INC. | 2024-11-21 | — | — | US | disclosed |
| US-20240349766-A1 | COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS | CLARA FOODS CO. (US) | 2024-10-24 | — | — | US | disclosed |
| WO-2024216169-A1 | GASTROINTESTINAL RETENTIVE FORMULATIONS OF ECHINOCANDINS | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-102100298-A | Emulsifier for improving melting resistance of ice cream and ice cream prepared by utilizing same | MASSON GROUP CO LTD | 2011-06-22 | — | — | CN | disclosed |
| CN-101411403-B | Feedstuff additive premix compound for Eriocheir sinensis | Guangdong hengxing group co ltd | 2011-05-25 | — | — | CN | disclosed |
| CN-101999475-A | Beta-glucan-containing powdered oil, preparation method and application thereof | UNIV BINZHOU | 2011-04-06 | — | — | CN | disclosed |
| CN-101933981-A | Traditional Chinese medicinal composition for treating syndrome of liver and gall of aquatic animals and preparation method thereof | TIANJIN RUIBEITE TECHNOLOGY DEV CO LTD | 2011-01-05 | — | — | CN | disclosed |
| CN-101904436-A | Fish and shrimp polyculture compound feed and preparation method thereof | ZHANJIANG HENGXING SPECIAL FEED CO LTD | 2010-12-08 | — | — | CN | disclosed |
| CN-101720868-A | Compound immunopotentiator for apostichopus japonicus | OCEAN UNIV CHINA | 2010-06-09 | — | — | CN | disclosed |
| CN-101460066-A | Extracts and methods comprising cinnamon species | HERBALSCIENCE SINGAPORE PTE LTD (US) | 2009-06-17 | — | — | CN | disclosed |
| CN-101411403-A | Feedstuff additive premix compound for Eriocheir sinensis | GUANGDONG HENGXING GROUP CO LT (CN) | 2009-04-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009787-A1 | Nitric Oxide Containing Foam Formulation for Topical Medical Use | NOS1, NOS2, NOS3 | LGALS8 479/4885LGALS3 1022/4885LGALS4 1408/4885 |
| US-20240382517-A1 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | NOS2, NOS1, NOS3 | LGALS8 962/4885LGALS3 899/4885LGALS4 1536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.